| Item |
Information |
|
Drug Groups
|
approved |
|
Description
|
Alizapride is a dopamine antagonist with prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. |
| Indication |
Alizapride is used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. |
| Pharmacology |
Alizapride is a dopamine antagonist. |
| Half Life |
3 hours |
| Elimination |
renal |
| References |
| • |
Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rozencweig M: Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol. 1988;22(4):316-20.
[Pubmed]
|
|
| External Links |
|
|